LNCARSR and renal cell carcinoma: LncARSR was the earliest discovered lncRNA which could be a mediator of sunitinib resistance in RCC by acting as a competing endogenous RNA and confer resistance to sensitive cells by exosome‐mediated transmission.13 To explore the potential function of lncARSR relatively in depth, our study performed a comprehensive analysis of the relationship between 2 genetic variants in lncARSR and the susceptibility of RCC, and finally found rs7859384 was associated with the decreased risk in 4 statistical models.